Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial.

Cheng, Junlin; Long, Jun; Zhang, Jingjing; Han, Le; Hu, Yunfang; Liu, Jianghui; Qiu, Runze; Zhu, Zhibin; Fan, Hongwei

Cheng, Junlin; Long, Jun; Zhang, Jingjing; Han, Le; Hu, Yunfang; Liu, Jianghui; Qiu, Runze; Zhu, Zhibin; Fan, Hongwei.

Afiliación

Cheng J; Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Long J; Nanjing Hongqiao Pharmaceutical Technology Research Institute Co Ltd, Nanjing, China.
Zhang J; Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Han L; Nanjing Hongqiao Pharmaceutical Technology Research Institute Co Ltd, Nanjing, China.
Hu Y; Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Liu J; Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Qiu R; Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zhu Z; Nanjing Hongqiao Pharmaceutical Technology Research Institute Co Ltd, Nanjing, China.
Fan H; Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Front Pharmacol ; 14: 1146309, 2023.

Article en En | MEDLINE | ID: mdl-37124221

Palabras clave

pharmacokinetics; safety; salvianolic acid B; tolerance; traditional Chinese medicine injection

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Tipo de estudio: Clinical_trials Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google